Home › Funds › UBS Group AG › BBNX
UBS Group AG position in BBNX
BETA BIONICS INC · Health Care
Latest position (Q2 2026)386.62K sh
Reported value held$6.06M
Portfolio Weight0.00%
First reportedQ1 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 124.34K | $1.52M | New |
| Q2 2025 | 96.06K | $1.40M | Reduce |
| Q3 2025 | 127.91K | $2.54M | Add |
| Q4 2025 | 251.44K | $7.66M | Add |
| Q1 2026 | 623.25K | $6.24M | Add |
| Q2 2026 | 386.62K | $6.06M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BBNX
- Vanguard Group 2.22M sh · $67.59M · Q4 2025
- Morgan Stanley 4.27M sh · $66.86M · Q2 2026
- BlackRock Inc 3.34M sh · $52.34M · Q2 2026
- Point72 Asset Management 2.25M sh · $35.33M · Q2 2026
- Geode Capital Management 1.07M sh · $16.82M · Q2 2026
- Millennium Management 956.24K sh · $14.98M · Q2 2026
- Balyasny Asset Management 855.68K sh · $13.41M · Q2 2026
- JPMorgan Chase & Co 703.36K sh · $11.96M · Q2 2026
- Farallon Capital Management 595.00K sh · $9.32M · Q2 2026
- Bank of America Corp 546.65K sh · $8.57M · Q2 2026
- Goldman Sachs Group 537.11K sh · $8.42M · Q2 2026